Study Participation:
This study requires participants to attend 9 in-clinic visits over 7 months. To participate in this study, you will receive a vaccine. Those who are eligible and attend the in-clinic visits will receive $75.00 per visit to compensate for time and travel.
Key Facts about the Marburg Virus:
- Marburg Virus Disease occurs in sporadic outbreaks primarily in Sub-Saharan Africa.
- Currently, there are no approved vaccines or treatments for the disease.
Please complete the survey below to express your interest in participating in IAVI's Protocol C104 "A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of the rVSVΔG-MARB-GP Vaccine in Adults in Good General Health".
Thank you!